RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/35008699http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/35008699http://www.w3.org/2000/01/rdf-schema#comment"The interleukin-21 receptor (IL-21R) can be upregulated in endothelial cells (EC) from ischemic muscles in mice following hind-limb ischemia (HLI), an experimental peripheral arterial disease (PAD) model, blocking this ligand-receptor pathway-impaired STAT3 activation, angiogenesis, and perfusion recovery. We sought to identify mRNA and microRNA transcripts that were differentially regulated following HLI, based on the ischemic muscle having intact, or reduced, IL-21/IL21R signaling. In this comparison, 200 mRNAs were differentially expressed but only six microRNA (miR)/miR clusters (and among these only miR-30b) were upregulated in EC isolated from ischemic muscle. Next, myoglobin-overexpressing transgenic (MgTG) C57BL/6 mice examined following HLI and IL-21 overexpression displayed greater angiogenesis, better perfusion recovery, and less tissue necrosis, with increased miR-30b expression. In EC cultured under hypoxia serum starvation, knock-down of miR-30b reduced, while overexpression of miR-30b increased IL-21-mediated EC survival and angiogenesis. In Il21r-/- mice following HLI, miR-30b overexpression vs. control improved perfusion recovery, with a reduction of suppressor of cytokine signaling 3, a miR-30b target and negative regulator of STAT3. Together, miR-30b appears both necessary and sufficient for IL21/IL-21R-mediated angiogenesis and may present a new therapeutic option to treat PAD if the IL21R is not available for activation."xsd:string
http://purl.uniprot.org/citations/35008699http://purl.org/dc/terms/identifier"doi:10.3390/ijms23010271"xsd:string
http://purl.uniprot.org/citations/35008699http://purl.uniprot.org/core/author"Yang L."xsd:string
http://purl.uniprot.org/citations/35008699http://purl.uniprot.org/core/author"Yuan M."xsd:string
http://purl.uniprot.org/citations/35008699http://purl.uniprot.org/core/author"Wang T."xsd:string
http://purl.uniprot.org/citations/35008699http://purl.uniprot.org/core/author"Leonard W.J."xsd:string
http://purl.uniprot.org/citations/35008699http://purl.uniprot.org/core/author"Spolski R."xsd:string
http://purl.uniprot.org/citations/35008699http://purl.uniprot.org/core/author"Farber C.R."xsd:string
http://purl.uniprot.org/citations/35008699http://purl.uniprot.org/core/author"Annex B.H."xsd:string
http://purl.uniprot.org/citations/35008699http://purl.uniprot.org/core/author"Ganta V.C."xsd:string
http://purl.uniprot.org/citations/35008699http://purl.uniprot.org/core/date"2021"xsd:gYear
http://purl.uniprot.org/citations/35008699http://purl.uniprot.org/core/name"Int J Mol Sci"xsd:string
http://purl.uniprot.org/citations/35008699http://purl.uniprot.org/core/pages"271"xsd:string
http://purl.uniprot.org/citations/35008699http://purl.uniprot.org/core/title"MicroRNA-30b Is Both Necessary and Sufficient for Interleukin-21 Receptor-Mediated Angiogenesis in Experimental Peripheral Arterial Disease."xsd:string
http://purl.uniprot.org/citations/35008699http://purl.uniprot.org/core/volume"23"xsd:string
http://purl.uniprot.org/citations/35008699http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/35008699
http://purl.uniprot.org/citations/35008699http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/35008699
http://purl.uniprot.org/uniprot/#_Q3UBS8-mappedCitation-35008699http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35008699
http://purl.uniprot.org/uniprot/#_Q3TA82-mappedCitation-35008699http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35008699
http://purl.uniprot.org/uniprot/#_Q3TAI3-mappedCitation-35008699http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35008699
http://purl.uniprot.org/uniprot/#_Q6PEU8-mappedCitation-35008699http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35008699
http://purl.uniprot.org/uniprot/#_Q9JHX3-mappedCitation-35008699http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35008699
http://purl.uniprot.org/uniprot/Q3TAI3http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/35008699
http://purl.uniprot.org/uniprot/Q9JHX3http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/35008699